Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Black Raspberry Extract for HNSCC
NCT06086925Phase 1Withdrawn
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of black raspberry in head and neck squamous cell carcinoma (HNSCC). Primary endpoint: H-score of biomarkers. Planned start Jun 2025; status: withdrawn.
02
Drugs
black raspberry
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT06086925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06086925.